A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors

Clinical trial NCT06553339 · RECRUITING

Trial details

NCT number: NCT06553339
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma

Start date: 2024-07-19
Primary completion: 2026-07-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.